VCYT
Veracyte IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$2.64B
P/E Ratio
40.35
EPS
$0.82
Beta
1.96
52W High
$50.71
52W Low
$22.61
50-Day MA
$33.46
200-Day MA
$35.49
Dividend Yield
—
Profit Margin
12.80%
Forward P/E
22.88
PEG Ratio
0.00
About Veracyte Inc
Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $517.14M |
| Gross Profit (TTM) | $373.20M |
| EBITDA | $84.40M |
| Operating Margin | 17.50% |
| Return on Equity | 5.34% |
| Return on Assets | 2.91% |
| Revenue/Share (TTM) | $6.58 |
| Book Value | $16.50 |
| Price-to-Book | 2.01 |
| Price-to-Sales (TTM) | 5.11 |
| EV/Revenue | 4.358 |
| EV/EBITDA | 25.15 |
| Quarterly Earnings Growth (YoY) | 712.00% |
| Quarterly Revenue Growth (YoY) | 18.50% |
| Shares Outstanding | $79.79M |
| Float | $79.02M |
| % Insiders | 0.70% |
| % Institutions | 109.38% |
Historical Volatility
HV 10-Day
42.13%
HV 20-Day
43.53%
HV 30-Day
50.85%
HV 60-Day
49.18%
HV Rank
63.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($46.55 target)
1
Strong Buy8
Buy2
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 5/2/2026